Found 48 matching trials
PCSK9 Inhibitors in Combination With Advanced Treatment Strategies for the Treatment of Advanced Colorectal Cancer With pMMR/MSS PHASE2 The purpose of this study is to preliminarily observe the efficacy and safe...
Show More Location
Multiple Locations
Learn More & Join Trial
Impact of PCSK9 Inhibitors on Coronary Plaque Composition and Vulnerability Assessed by Optical Coherence Tomography PHASE4 The study is a prospective, open-label, randomized, single-center study inv...
Show More Location
Beijing Anzhen Hospital
Learn More & Join Trial
Early Administration of PCSK9 Inhibitors After Thrombectomy for Atherosclerotic Acute Ischemic Stroke: A Randomized Controlled Trial PHASE4 This study (EPOCH-TECT) was a single-center, randomized, open-label, blinde...
Show More Location
Affiliated Hospital of Xuzhou Medical University
Learn More & Join Trial
Evaluation of Adherence, Persistence and Efficacy of Treatment With PCSK9 Inhibitors in Italy N/A Evaluation of adherence, persistence and efficacy of treatment with PCSK9 i...
Show More Location
Ospedali dell'Ovest Vicentino
Learn More & Join Trial
Effect of Combined Lipid-lowering Therapy on Atherosclerotic Plaque Vulnerability in Patients With ACS NA The study is prospective, open-label, randomized, single-center study invol...
Show More Location
Samara Regional Cardiology Dispansery
Learn More & Join Trial
PCSK9 Inhibitor With Statin Therapy for Asymptomatic Intracranial Atherosclerosis PHASE4 This is a prospective, multicenter, open-label, blinded-endpoint, randomize...
Show More Location
Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
Learn More & Join Trial
Very Early PCSK9 Inhibition for Acute Myocardial Infarction NA Acute myocardial infarction (AMI) remains a major cause of morbidity and mo...
Show More Location
Zhongshan Hospital, Fudan University
Learn More & Join Trial
LAPLACE-TIMI 57: Low-density Lipoprotein Cholesterol (LDL-C) Assessment With PCSK9 monoclonaL Antibody Inhibition Combined With Statin thErapy PHASE2 To evaluate the effect of 12 weeks of subcutaneous (SC) evolocumab (AMG 145...
Show More Learn More & Join Trial
Efficacy and Safety of Pitavastatin and PCSK9 Inhibitors in Liver Transplant Patients PHASE4 To study the efficacy and safety of pitavastatin and PCSK9 inhibitors in li...
Show More Status
Active Not Recruiting
Location
National Medical Research Centre for Therapy and Preventive Medicine of the Ministry of Health of Russia
Learn More & Join Trial
Multicenter Real-World Cohort Study Evaluating the Impact of Early Intensive Lipid-Lowering Therapy on the Prognosis of Acute Coronary Syndrome Patients(ELITE-ACS) N/A The purpose of this clinical trial is to evaluate the impact of early initi...
Show More Location
Chinese PLA General Hospital
Learn More & Join Trial